Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-26 @ 3:14 PM
NCT ID:
NCT07458061
Brief Summary:
The objectives of this investigation are to assess:
1. whether oral K9 is safe in subjects with DME, and
2. whether oral K9 improves BCVA compared to oral placebo
Study:
NCT07458061
Study Brief:
Protocol Section:
NCT07458061